Literature DB >> 29654803

Donor cell chimerism evaluation in cerebrospinal fluid by short tandem repeat analysis following allogeneic hematopoietic stem cell transplantation.

Jessica L Spruit1, Omar R Fagoaga2, Süreyya Savaşan3.   

Abstract

Cerebrospinal fluid (CSF) cell count, morphology and flow cytometric evaluations are used to investigate central nervous system (CNS) involvement in leukemia/lymphoma. We performed CSF short tandem repeat (STR) analysis to monitor CSF chimerism status and evaluate for disease involvement in 11 asymptomatic pediatric allogeneic hematopoietic stem cell transplantation (HSCT) recipients with hemato-lymphoid neoplasms and high risk for or history of CNS involvement. Eighteen (64%) of the samples with median CSF cell count of 1/mm3 with 90% lymphocytes gave conclusive STR results, suggesting that this DNA-based method can be used in monitoring CSF chimerism status after HSCT with an acceptable yield.
Copyright © 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebrospinal fluid; Donor chimerism; Hematopoietic stem cell transplantation; Short tandem repeat analysis

Mesh:

Year:  2018        PMID: 29654803      PMCID: PMC6854661          DOI: 10.1016/j.humimm.2018.04.001

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  3 in total

1.  Chimerism analysis on mononuclear cells in the CSF after allogeneic bone marrow transplantation.

Authors:  S Hibi; K Tsunamoto; S Todo; T Sawada; Y Ueda; M Taniwaki; M Naya; M Hojo; S Imashuku
Journal:  Bone Marrow Transplant       Date:  1997-09       Impact factor: 5.483

2.  Cerebrospinal fluid chimerism analysis in patients with neurological symptoms after allogeneic cell transplantation.

Authors:  M Waterhouse; I Bartsch; H Bertz; J Duyster; J Finke
Journal:  Bone Marrow Transplant       Date:  2015-10-05       Impact factor: 5.483

3.  Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.

Authors:  Paul D Harker-Murray; Avis J Thomas; John E Wagner; Daniel Weisdorf; Xianghua Luo; Todd E DeFor; Michael R Verneris; Kathryn E Dusenbery; Margaret L MacMillan; Jakub Tolar; K Scott Baker; Paul J Orchard
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

  3 in total
  2 in total

1.  Allogeneic hematopoietic stem cell transplantation for primary central nervous system lymphoma.

Authors:  Thomas Mika; Swetlana Ladigan; Alexander Baraniskin; Deepak Vangala; Sabine Seidel; Olaf Hopfer; Michael Kiehl; Roland Schroers
Journal:  Haematologica       Date:  2019-08-08       Impact factor: 9.941

2.  Low donor chimerism may be sufficient to prevent demyelination in adrenoleukodystrophy.

Authors:  Takahiro Ikeda; Yuta Kawahara; Akihiko Miyauchi; Hitomi Niijima; Rieko Furukawa; Nobuyuki Shimozawa; Akira Morimoto; Hitoshi Osaka; Takanori Yamagata
Journal:  JIMD Rep       Date:  2021-11-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.